Quantitative TMT-based proteomic analysis revealed that DHODH inhibition by Regorafenib suppresses the mevalonate pathway, disrupts lipid droplet formation, and induces nuclear translocation of SQLE in neuroblastoma cells. Here, DHODH is linked to neuroblastoma.